Your session is about to expire
← Back to Search
NYHA Classification Guide for Heart Failure (CLASS-HF Trial)
N/A
Recruiting
Led By Marilyn A. Prasun, PhD
Research Sponsored by Board of Trustees of Illinois State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
A documented confirmed diagnosis of Heart Failure (HF)
Ability to walk without assistance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
CLASS-HF Trial Summary
This trial studies how well a classification guide helps healthcare providers treat heart failure patients. They will compare patient results from the guide to a standardized test. Then they will use the guide in a clinic setting to see how healthcare providers perceive it.
Who is the study for?
Adults aged 18-90 with confirmed heart failure, able to walk unassisted and communicate in English. They must be under a cardiologist's care, oriented, and not have conditions like uncontrolled high blood pressure or recent severe cardiac events.Check my eligibility
What is being tested?
The trial is examining the New York Heart Association Classification Guide used by healthcare providers to assess heart failure severity. It involves comparing this guide's results with a standard 6-minute walk test and evaluating its use over 30 days in clinical practice.See study design
What are the potential side effects?
Since this study focuses on assessment methods rather than medications or invasive treatments, there are no direct side effects from interventions being tested.
CLASS-HF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been officially diagnosed with Heart Failure.
Select...
I can walk on my own without help.
Select...
I am between 18 and 89 years old.
Select...
I am aware of who I am, where I am, and the current time.
CLASS-HF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Barriers to implementation of the New York Heart Association (NYHA) Classification Guide
Documentation after Implementation of the New York Heart Association (NYHA) Classification Guide
Facilitators to implementation of the New York Heart Association (NYHA) Classification Guide
+2 moreCLASS-HF Trial Design
1Treatment groups
Experimental Treatment
Group I: Single Intervention Study ArmExperimental Treatment1 Intervention
All participants with HF will be evaluated by their HF providers who will use the NYHA Classification Guide to assist with assignment of HF class. The participant will then complete a 6-minute walk test. Subsequently participating providers will utilize the guide to assess and assign the class of their HF patients in practice.
Find a Location
Who is running the clinical trial?
University of Colorado, DenverOTHER
1,738 Previous Clinical Trials
2,149,422 Total Patients Enrolled
25 Trials studying Heart Failure
7,154 Patients Enrolled for Heart Failure
Board of Trustees of Illinois State UniversityLead Sponsor
Lancaster General HospitalOTHER
22 Previous Clinical Trials
3,688 Total Patients Enrolled
4 Trials studying Heart Failure
1,042 Patients Enrolled for Heart Failure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been officially diagnosed with Heart Failure.I have an ongoing heart infection.I had a heart attack or heart surgery in the last 30 days.My asthma is not well-managed.I am suspected to have a type of aneurysm that splits the layers of my artery wall.I have had a heart shock treatment due to irregular heartbeat in the last month.I have inflammation of the heart or its surrounding tissues.I have an irregular heartbeat that is not under control.I have fluid in my lungs.Your blood pressure is very high and not well controlled, with readings higher than 180 over 100.I am experiencing severe breathing problems.I do not have any recent illnesses that could worsen with exercise.I have severe symptoms from a narrowed heart valve.I have a lung clot or lung infection.I can walk on my own without help.You have a left ventricular assist device.I am able to understand and follow study procedures.I am between 18 and 89 years old.I am aware of who I am, where I am, and the current time.I have had blood clots in my legs.Your oxygen level while resting is below 90%.I have not had unstable chest pain in the last 30 days.
Research Study Groups:
This trial has the following groups:- Group 1: Single Intervention Study Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What criteria must participants meet in order to be eligible for this study?
"Entry criteria for this clinical trial mandates that patients possess a diagnosis of heart failure and be between 18 - 90 years old. A total of 104 participants are being sought to participate in the study."
Answered by AI
Does this research project permit participants aged 65 and over?
"According to the requirements for this clinical trial, individuals must be over 18 years of age and no older than 90."
Answered by AI
Are there any open slots to join this clinical trial?
"As of April 17th 2023, this clinical trial is still accepting participants. Information hosted on the website states that it was initially put up for recruitment on March 17th 2023."
Answered by AI
What is the aggregate number of individuals participating in this research study?
"To execute this medical trial, 104 candidates who conform to the specified entry requirements are needed. Eligible patients can receive care from various locations such as Carle BroMenn Medical Center in Normal, Illinois or Lancaster General Health/Penn Medicine in Pennsylvania."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger